• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Tekla Healthcare Investors

+ Add to Watchlist

XHQHX:US

30.74 USD 0.27 0.87%

As of 20:00:00 ET on 10/29/2014.

Snapshot for Tekla Healthcare Investors (XHQHX)

Year To Date: +26.06% 3-Month: +10.35% 3-Year: +36.89% 52-Week Range: 23.48 - 31.01
1-Month: +3.85% 1-Year: +34.67% 5-Year: +26.21% Beta vs BTK: 0.80

Mutual Fund Chart for XHQHX

No chart data available.
  • XHQHX:US 30.74
  • 1M
  • 1Y
Interactive XHQHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XHQHX

H&Q Healthcare Investors is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long-term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.

Inception Date: 04-22-1987 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for XHQHX

NAV (on 2014-10-29) 30.74
Assets (M) (on 2014-10-29) 1,101.00
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for XHQHX

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-08-27) 0.56
Dividend Yield (ttm) 6.83

Fees & Expenses for XHQHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.95
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.26

Top Fund Holdings for XHQHX

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,039,942 78,151,641 10.619%
Celgene Corp 706,182 59,658,255 8.106%
Regeneron Pharmaceuticals Inc 178,740 49,196,398 6.685%
Biogen Idec Inc 132,195 36,981,551 5.025%
Alexion Pharmaceuticals Inc 259,405 34,516,429 4.690%
Amgen Inc 286,769 32,737,549 4.448%
Actavis plc 158,892 26,693,856 3.627%
Vertex Pharmaceuticals Inc 346,735 25,762,411 3.501%
Perrigo Co PLC 154,896 23,770,340 3.230%
iShares Nasdaq Biotechnology E 97,826 22,212,372 3.018%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil